Adient (NYSE:ADNT) Price Target Cut to $27.00 by Analysts at UBS Group

Adient (NYSE:ADNTFree Report) had its target price reduced by UBS Group from $31.00 to $27.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a neutral rating on the stock.

A number of other research firms also recently weighed in on ADNT. Barclays decreased their price target on shares of Adient from $37.00 to $34.00 and set an equal weight rating on the stock in a research note on Tuesday, May 7th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Adient from $32.00 to $30.00 and set a hold rating on the stock in a research note on Monday, May 6th. Bank of America reduced their price target on shares of Adient from $50.00 to $46.00 and set a buy rating on the stock in a research report on Wednesday, April 10th. BNP Paribas upgraded shares of Adient from an underperform rating to a neutral rating and set a $26.00 price target on the stock in a research report on Monday, July 1st. Finally, JPMorgan Chase & Co. reduced their price target on shares of Adient from $40.00 to $37.00 and set a neutral rating on the stock in a research report on Monday, April 22nd. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of Hold and a consensus price target of $36.22.

Read Our Latest Report on Adient

Adient Stock Down 0.4 %

ADNT opened at $24.07 on Wednesday. Adient has a fifty-two week low of $22.93 and a fifty-two week high of $46.51. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.13 and a quick ratio of 0.91. The firm’s fifty day moving average price is $26.67 and its two-hundred day moving average price is $30.85. The company has a market capitalization of $2.16 billion, a P/E ratio of 14.77, a P/E/G ratio of 0.31 and a beta of 2.19.

Adient (NYSE:ADNTGet Free Report) last posted its quarterly earnings results on Friday, May 3rd. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.15. Adient had a net margin of 1.04% and a return on equity of 8.72%. The firm had revenue of $3.75 billion for the quarter, compared to the consensus estimate of $3.80 billion. During the same quarter in the previous year, the company earned $0.32 earnings per share. The business’s revenue was down 4.1% compared to the same quarter last year. On average, analysts anticipate that Adient will post 2.26 EPS for the current year.

Insiders Place Their Bets

In other Adient news, Director Peter Carlin sold 4,207 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $28.90, for a total transaction of $121,582.30. Following the completion of the sale, the director now directly owns 28,352 shares of the company’s stock, valued at approximately $819,372.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company’s stock.

Institutional Trading of Adient

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. CWM LLC increased its stake in shares of Adient by 44.5% in the 2nd quarter. CWM LLC now owns 1,439 shares of the company’s stock valued at $36,000 after acquiring an additional 443 shares during the last quarter. Partnership Wealth Management LLC bought a new stake in shares of Adient in the 4th quarter valued at about $83,000. Covestor Ltd increased its stake in shares of Adient by 201.5% in the 1st quarter. Covestor Ltd now owns 3,307 shares of the company’s stock valued at $109,000 after acquiring an additional 2,210 shares during the last quarter. Lazard Asset Management LLC bought a new stake in shares of Adient in the 1st quarter valued at about $135,000. Finally, Headlands Technologies LLC bought a new stake in shares of Adient in the 1st quarter valued at about $159,000. 92.44% of the stock is owned by institutional investors.

Adient Company Profile

(Get Free Report)

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

See Also

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.